I. Tarkun Et Al. , "Anticardiolipin and anti-beta 2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus," DIABETES RESEARCH AND CLINICAL PRACTICE , vol.68, no.3, pp.181-187, 2005
Tarkun, I. Et Al. 2005. Anticardiolipin and anti-beta 2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.68, no.3 , 181-187.
Tarkun, I., Hacihanefioglu, A., Tarkun, P., ÇETİNARSLAN, B., & Canturk, Z., (2005). Anticardiolipin and anti-beta 2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.68, no.3, 181-187.
Tarkun, İLHAN Et Al. "Anticardiolipin and anti-beta 2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus," DIABETES RESEARCH AND CLINICAL PRACTICE , vol.68, no.3, 181-187, 2005
Tarkun, İLHAN Et Al. "Anticardiolipin and anti-beta 2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.68, no.3, pp.181-187, 2005
Tarkun, I. Et Al. (2005) . "Anticardiolipin and anti-beta 2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.68, no.3, pp.181-187.
@article{article, author={İLHAN TARKUN Et Al. }, title={Anticardiolipin and anti-beta 2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus}, journal={DIABETES RESEARCH AND CLINICAL PRACTICE}, year=2005, pages={181-187} }